There are many innovations in the cosmetic sector that can be the subject of patent applications and these may be…
Read More
Medical
Filter By
Protecting AI diagnostics – two bites at the AIpple?
The use of AI has revolutionised the speed and accuracy of diagnosis for a host of conditions including breast cancer,…
Read More
Data versus time in clinical trials: attaining the perfect balance
Clinical trials are an expensive and risky business. The investment of time, resources and costs grows with progression through the…
Read More
Marcos Kauffman joins Barker Brettell’s IP Valuation Service
Intellectual Property (IP) firm Barker Brettell has announced that Marcos Kauffman has been appointed IP Valuations Consultant to its IP…
Read More
IP owners beware: unscrupulous or scam IP services are targeting you
For a number of years now, owners of different types of IP rights have been receiving unsolicited mail and invoices…
Read More
Don’t fall into an indefensible opposition trap – you can use a routine pre-grant patent check in Europe
Many European patent applications are prosecuted through to grant where through determined and persuasive argument, luck, or an Examiner oversight,…
Read More
Are smartphones about to get smarter? With terahertz spectroscopy, it certainly looks that way…
The number of UK smartphones users reached 55.5 million in 2021. This means that nearly 83% of the population have…
Read More
How do I decide whether to opt out of the Unified Patent Court?
The European Patent Office (EPO) and participating European Union countries are in the final stages of establishing the Unitary Patent…
Read More
Can you keep a trade secret? Understanding pharmaceutical IP
Patents are the ‘go-to’ form of Intellectual Property (IP) protection for new pharmaceuticals. Through patents, protection can be attained for…
Read More
Digital technology, pharmaceutical and green transport patent applications increase as the EPO’s latest figures confirm European patent applications return to growth
The European Patent Office’s latest patent index shows that patent applications filed at the EPO hit a record number in…
Read More
The verdict is in: it’s a yes from the FDA for the controversial Alzheimer’s drug, after a tricky year for Biogen
The pharmaceutical industry has eagerly awaited the decision from the US Food and Drug Administration (FDA) on the first new…
Read More
Keeping in line: intraoperative surgical guidance innovation
Surgery is, by its very nature, an invasive procedure. It can be transformative to the quality of life of those…
Read More